Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Sampson Insider Profile
4 Followers
Mark Sampson, Chief Medical Officer at Shield Therapeutics, holds 83.70K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Mark Sampson Bought 44,917p shares of Shield Therapeutics on Apr 27, 2019 for an estimated value of 39.99K.
Mark Sampson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Medical Officer
Roles that Mark Sampson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark Sampson
Mark Sampson's Trading History
List of latest transactions for each holding click on a transaction to see Mark Sampson's performance on stock
You May Also Like
Mark Sampson insider profile FAQ
What is the percentage of profitable transactions made by Mark Sampson?
The percentage of profitable transactions made by Mark Sampson is ―.
What is the average return per transaction made by Mark Sampson?
The average return per transaction made by Mark Sampson is ―.
What stocks does Mark Sampson hold?
Mark Sampson holds: GB:STX stocks.
What was Mark Sampson’s latest transaction?
Mark Sampson latest transaction was an Informative Buy of 39.99K.
What was Mark Sampson's most profitable transaction?
Mark Sampson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Sampson's role in Shield Therapeutics?
Mark Sampson's role in Shield Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.